Rejoni Raises $25 Million to Advance Juveena Hydrogel System Toward FDA Approval

Rejoni, Inc., a clinical-stage medical technology company focused on uterine health, has secured $25 million in financing to support the... Read More

The post Rejoni Raises $25 Million to Advance Juveena Hydrogel System Toward FDA Approval appeared first on citybiz.